Associated Papers
NF-κB pathway variants in Iranian patients with inborn errors of immunity.
Fathi N et al.
Expert Review of Clinical Immunology, 2025
Two NEMO-like Ubiquitin-Binding Domains in CEP55 Differently Regulate Cytokinesis.
Said Halidi KN et al.
Iscience, 2019
Inhibition of Canonical NF-κB Signaling by a Small Molecule Targeting NEMO-Ubiquitin Interaction.
Vincendeau M et al.
Scientific Reports, 2016
Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
Ramírez-Alejo N et al.
Clinical Immunology (orlando, Fla.), 2015
Rare mendelian primary immunodeficiency diseases associated with impaired NF-κB signaling.
Paciolla M et al.
Genes and Immunity, 2015
EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
Fusco F et al.
International Reviews of Immunology, 2015
Linear ubiquitination-mediated NF-κB regulation and its related disorders.
Tokunaga F
Journal of Biochemistry, 2013
Disseminated BCG infection mimicking metastatic nasopharyngeal carcinoma in an immunodeficient child with a novel hypomorphic NEMO mutation.
Imamura M et al.
Journal of Clinical Immunology, 2011
New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein.
Hubeau M et al.
Blood, 2011
Select a paper to view details